BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Montemagno C, Pagès G. Resistance to Anti-angiogenic Therapies: A Mechanism Depending on the Time of Exposure to the Drugs. Front Cell Dev Biol 2020;8:584. [PMID: 32775327 DOI: 10.3389/fcell.2020.00584] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 8.0] [Reference Citation Analysis]
Number Citing Articles
1 Armani G, Pozzi E, Pagani A, Porta C, Rizzo M, Cicognini D, Rovati B, Moccia F, Pedrazzoli P, Ferraris E. The heterogeneity of cancer endothelium: The relevance of angiogenesis and endothelial progenitor cells in cancer microenvironment. Microvasc Res 2021;138:104189. [PMID: 34062191 DOI: 10.1016/j.mvr.2021.104189] [Reference Citation Analysis]
2 Herkenne S, Scorrano L. OPA1, a new mitochondrial target in cancer therapy. Aging (Albany NY) 2020;12:20931-3. [PMID: 33216729 DOI: 10.18632/aging.104207] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Marzagalli M, Fontana F, Raimondi M, Limonta P. Cancer Stem Cells-Key Players in Tumor Relapse. Cancers (Basel) 2021;13:376. [PMID: 33498502 DOI: 10.3390/cancers13030376] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
4 Ghinea N. Anti-Angiogenic Therapy: Albumin-Binding Proteins Could Mediate Mechanisms Underlying the Accumulation of Small Molecule Receptor Tyrosine Kinase Inhibitors in Normal Tissues with Potential Harmful Effects on Health. Diseases 2021;9:28. [PMID: 33920299 DOI: 10.3390/diseases9020028] [Reference Citation Analysis]
5 Ribatti D, Solimando AG, Pezzella F. The Anti-VEGF(R) Drug Discovery Legacy: Improving Attrition Rates by Breaking the Vicious Cycle of Angiogenesis in Cancer. Cancers (Basel) 2021;13:3433. [PMID: 34298648 DOI: 10.3390/cancers13143433] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
6 Luo Y, Ge P, Wang M, Chen H, Liu J, Wei T, Jiang Y, Qu J, Chen H. Research progress of DLX6-AS1 in human cancers. Hum Cell 2021;34:1642-52. [PMID: 34508305 DOI: 10.1007/s13577-021-00613-0] [Reference Citation Analysis]
7 Aspriţoiu VM, Stoica I, Bleotu C, Diaconu CC. Epigenetic Regulation of Angiogenesis in Development and Tumors Progression: Potential Implications for Cancer Treatment. Front Cell Dev Biol 2021;9:689962. [PMID: 34552922 DOI: 10.3389/fcell.2021.689962] [Reference Citation Analysis]